Clinical Trial Detail

NCT ID NCT03572478
Title Rucaparib and Nivolumab in Patients With Prostate or Endometrial Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Chicago
Indications

endometrial cancer

prostate cancer

Therapies

Nivolumab + Rucaparib

Nivolumab

Rucaparib

Age Groups: adult senior

No variant requirements are available.